Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study

医学 胃分流术 Roux-en-Y吻合术 临床终点 吻合 人口 回流 前瞻性队列研究 外科 不利影响 随机对照试验 内科学 疾病 减肥 肥胖 环境卫生
作者
Maud Robert,Tigran Poghosyan,Delphine Maucort‐Boulch,Alexandre Filippello,Robert J. Caiazzo,A. Sterkers,Litavan Khamphommala,Fabián Reche,Vincent Malherbe,Adriana Torcivia,Toufic Saber,Dominique Delaunay,Carole Langlois,Augustin Suffisseau,Sylvie Bin,Emmanuel Disse,François N. Pattou
出处
期刊:The Lancet Diabetes & Endocrinology [Elsevier BV]
卷期号:12 (4): 267-276 被引量:68
标识
DOI:10.1016/s2213-8587(24)00035-4
摘要

Background The multicentre randomised trial YOMEGA (NCT02139813) comparing the one anastomosis gastric bypass (OAGB) with the Roux-en-Y gastric bypass (RYGB) confirmed the non-inferiority of OAGB on weight loss outcomes at 24 months. We aimed to report weight loss, metabolic, and safety outcomes at 5 years. Methods YOMEGA is a prospective, open-label, non-inferiority, randomised trial conducted at nine centres in France. Inclusion criteria were BMI of 40 kg/m2 or more, or 35 kg/m2 or more with comorbidities. Key exclusion criteria were severe gastro-oesophageal reflux disease or Barrett's oesophagus and previous bariatric surgery. Patients were randomly assigned (1 :1) to OAGB (one gastrojejunal anastomosis with a 200 cm biliopancreatic limb) or RYGB (with a 150 cm alimentary limb and a 50 cm biliary limb), stratified by centre, with blocks of variable size. The primary endpoint of this extension study was percentage excess BMI loss and was analysed in the per-protocol population, including patients with data who were operated on with the technique randomly assigned to them and excluding patients with major deviations from the protocol during the follow-up (change of surgical technique, death, or withdrawal of consent). Non-inferiority was concluded for the primary endpoint if the upper bound of the CI was less than the non-inferiority limit (7 percentage points). YOMEGA is registered with ClinicalTrials.gov, NCT02139813, and the 5-year follow-up of YOMEGA is registered with ClinicalTrials.gov, NCT05549271. Findings Between May 13, 2014, and March 2, 2016, 253 patients were randomly assigned to OAGB (n=129) or RYGB (n=124), and from these patients 114 in the OAGB group and 118 in the RYGB group were included in the per-protocol analysis. In the per-protocol population, at baseline, mean age was 43·0 years (SD 10·8), mean BMI was 44·0 kg/m2 (5·6), 54 (23%) patients were male and 178 (77%) were female; 55 (27%) of 207 patients had type 2 diabetes. After 5 years, mean percentage excess BMI loss was –75·6% (SD 28·1) in the OAGB group versus –71·4% (SD 29·8) in the RYGB group, confirming non-inferiority (mean difference –4·1% [90% CI –12·0 to 3·7], p=0·0099). Remission of type 2 diabetes was similar in both groups. Nutritional status did not differ; the most common adverse event was clinical gastro-oesophageal reflux disease, occurring in 27 (41%) of 66 patients in the OAGB group versus 14 (18%) of 76 patients in the RYGB group (p=0·0030). Among serious adverse events, ten (8%) of 127 patients converted from OAGB to RYGB. 171 (68%) of 253 patients were followed up. Interpretation OAGB was not inferior to RYGB regarding percentage excess BMI loss at 5 years with similar metabolic outcomes. The high rate of clinical gastro-oesophageal reflux disease after OAGB raises questions about its long-term consequences, which need to be further investigated. Funding Medtronic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
云城完成签到,获得积分10
刚刚
情怀的应助被大宝君采纳,获得30
1秒前
1秒前
2秒前
2秒前
2秒前
2秒前
3秒前
dddd完成签到,获得积分10
3秒前
JamesPei的应助被云泽先生采纳,获得10
3秒前
双双完成签到 ,获得积分10
3秒前
crazy完成签到 ,获得积分10
3秒前
Jun给洛楠的求助进行了留言
4秒前
wkkkk发布了新的文献求助10
4秒前
4秒前
zhubb完成签到 ,获得积分10
4秒前
义气糜发布了新的文献求助10
5秒前
5秒前
明理的行恶完成签到,获得积分10
5秒前
学术糍粑关注了科研通微信公众号
5秒前
Aliangkou完成签到,获得积分10
5秒前
6秒前
6秒前
万能图书馆的应助被小王采纳,获得10
6秒前
风格化橙发布了新的文献求助10
6秒前
领导范儿的应助被你好采纳,获得10
6秒前
牙牙乐发布了新的文献求助20
6秒前
7秒前
科研牛马发布了新的文献求助10
8秒前
9秒前
4477完成签到,获得积分10
9秒前
平常的樱桃完成签到 ,获得积分10
9秒前
jianghu发布了新的文献求助10
9秒前
wanci的应助被王云鹏采纳,获得10
9秒前
9秒前
踏实映天发布了新的文献求助10
9秒前
kj发布了新的文献求助10
10秒前
CipherSage的应助被kk采纳,获得10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172032
求助须知:如何正确求助?哪些是违规求助? 9564751
关于积分的说明 21776350
捐赠科研通 7763610
什么是DOI,文献DOI怎么找? 3431110
关于科研通互助平台的介绍 2554971
邀请新用户注册赠送积分活动 2476130